The mTOR Conundrum: Essential for Muscle Function, but Dangerous for Survival
- 1 November 2016
- journal article
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 17 (11) , 963-966
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) CodeJournal of the American Medical Directors Association, 2016
- Aging Successfully: The Key to Aging in PlaceJournal of the American Medical Directors Association, 2015
- Rapid screening for sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2015
- Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and NeurodegenerationCurrent Topics in Medicinal Chemistry, 2015
- Interventions to Slow Aging in Humans: Are We Ready?Aging Cell, 2015
- Testosterone Signals through mTOR and Androgen Receptor to Induce Muscle HypertrophyMedicine & Science in Sports & Exercise, 2013
- The Role of mTORC1 in Regulating Protein Synthesis and Skeletal Muscle Mass in Response to Various Mechanical Stimuli2013
- Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated agingAging, 2012
- Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle massJournal of Applied Physiology, 2006
- Inhibition of the immune response by rapamycin, a new antifungal antibioticCanadian Journal of Physiology and Pharmacology, 1977